Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apeiron Partners is a boutique investment bank and strategic advisory firm focused exclusively on the life sciences industry. Founded in 2000 and headquartered in Boston, the firm specializes in corporate spin-outs, technology licensing, and the incubation of new biotechnology companies. Apeiron is distinguished by its "principal-based" advisory model, where it identifies high-potential assets within large pharmaceutical companies and structures them into independent, venture-backed entities. Notable companies formed or advised by Apeiron include Targacept, Artisan Pharma, Biocritica, and KBI BioPharma. The firm's expertise spans oncology, infectious diseases, and critical care, providing strategic guidance to both emerging biotechs and established pharmaceutical leaders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apeiron Partners.